NEVRO CORP. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 26 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-11-05: Reporting owner Behbahani Ali; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-11-05: Reporting owner Enxing Michael; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-11-05: Reporting owner Galligan Andrew H; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-11-05: Reporting owner Walker Andre; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-11-05 | Behbahani Ali Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,477 8,477 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 | Enxing Michael Officer (VP of Sales & Marketing) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,257 28,257 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 | Galligan Andrew H Officer (VP of Finance , CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,514 56,514 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 | Walker Andre Officer (Senior VP,Research&Development) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,257 28,257 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 | Fischer Frank M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,477 8,477 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 | Elghandour Rami Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,514 56,514 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 | McCormick Shawn Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,129 14,129 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 | DEMANE MICHAEL F Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +141,285 141,285 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 | PLIAM NATHAN B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,477 8,477 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 | JAEGER WILFRED E Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,477 8,477 owned after | $18.00 exercise price | 2014-11-07 | |
| 2014-11-05 holding as of filing | Enxing Michael Officer (VP of Sales and Marketing) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Enxing Michael Officer (VP of Sales and Marketing) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Galligan Andrew H Officer (VP of Finance, CFO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.44 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Galligan Andrew H Officer (VP of Finance, CFO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Galligan Andrew H Officer (VP of Finance, CFO) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Walker Andre Officer (Sr VP, Research & Development) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.96 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Walker Andre Officer (Sr VP, Research & Development) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $0.96 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Walker Andre Officer (Sr VP, Research & Development) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.44 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Walker Andre Officer (Sr VP, Research & Development) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $1.44 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Walker Andre Officer (Sr VP, Research & Development) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Walker Andre Officer (Sr VP, Research & Development) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Shankar Balakrishnan Officer (VP, Operations) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Elghandour Rami Officer (President) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | Elghandour Rami Officer (President) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-11-05 holding as of filing | DEMANE MICHAEL F Director, Officer (Chief Executive Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.60 exercise price | 2014-11-05 | ||
| 2014-06-18 | DEMANE MICHAEL F Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −58,906 158,593 owned after | $3.60 exercise price | 2014-11-07 |